The abstract is read at the publisher; the summary is JClub's.
Liver transplantation is increasingly supported for selected patients with primary and metastatic liver malignancies, with reported improved survival and reduced recurrence using stringent selection and multimodal therapy.
- Why it matters: Traditional liver transplant use has been limited, and clinicians need evidence-based ways to expand eligibility while maintaining oncologic safety across multiple cancer types.
- What they did: The review synthesizes evidence from clinical series, registries, and experimental protocols, focusing on selection criteria, downstaging with locoregional and systemic regimens, donor utilization, and immunosuppression integration.
- The result: Across the compiled studies, applying strict selection plus multimodal treatment is linked to better survival and lower recurrence, supporting transplant oncology as a multidisciplinary cancer-care cornerstone.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.